Clinical trial
Targeting FMO-Mediated TMAO Formation in Kidney Disease (TMAO) Study
NCT03152097 is registered in ClinicalTrials.gov with University of Pittsburgh as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Targeting FMO-Mediated TMAO Formation in Kidney Disease (TMAO) Study
- Lead sponsor
- University of Pittsburgh
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 30, 2018
- Completion date
- August 30, 2019
- Enrollment
- 13 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.